Skip to main content
Signal8

Mei Baisong

SEC insider (Form 3/4/5 filer). CIK 0001938499. Chief Medical Officer at CITY THERAPEUTICS, INC. (CTY) and 1 other issuer. 2 reported Form 4/5 transactions since Sep 2024; latest on Dec 3, 2024. Located in CAMBRIDGE, MA.

Companies Mei Baisong has filed insider reports for

  • CITY THERAPEUTICS, INC. (CTY): Officer, Chief Medical Officer
  • Editas Medicine, Inc. (EDIT): Officer, EVP, CHIEF MEDICAL OFFICER
Mei Baisong profile photo

Mei Baisong

CIK: 0001938499

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (100.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

CITY THERAPEUTICS, INC. logo
CTY

CITY THERAPEUTICS, INC.

Officer
Editas Medicine, Inc. logo
EDIT

Editas Medicine, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Editas Medicine, Inc. logo
    EDIT

    Editas Medicine, Inc.

    Dec 3, 2024
    Sale
    Direct
    541 shares at avg. $2.08$1K
  • Editas Medicine, Inc. logo
    EDIT

    Editas Medicine, Inc.

    Sep 4, 2024
    Sale
    Direct
    518 shares at avg. $3.42$2K

1-2 of 2